While male pentathletes have competed at every Olympic Games since Stockholm 1912, Steph Cook became the first women’s Olympic modern pentathlon champion 88 years later, at the Sydney 2000 Games. The Great Britain star talks us through how she combined a hectic life as a doctor with going for gold – and how her fascinating sport, rooted in Olympic history, has evolved in the modern world.
Junior doctors in British hospitals are famously, perhaps notoriously, overworked. So the idea of pulling 15-hour shifts while also putting in the amount of training required to become an Olympian might seem physically impossible. Steph Cook, however, somehow managed it, and in a sport consisting of five disciplines – fencing, swimming, show jumping, shooting and running.
“It was crazy,” Cook said with a laugh, reflecting on her years before becoming the first women’s Olympic modern pentathlon champion. “I was studying medicine at Oxford, which is where I’d taken up modern pentathlon, and once I graduated I knew I needed to make a decision.
“Was I going to continue with sport or become a junior doctor? I decided I’d try to do both. I was doing up to 100 hours a week in the hospital while still training and competing. I remember coming off a night shift and flying straight to Poland for a World Cup. Somehow I kept going.”
Combining saving lives with creeping up the world rankings, Cook was clearly a multi-tasker of the highest calibre. No wonder the Olympic sport conceived to find the best all-round athletes appealed to her.
“Growing up, I’d done a bit of riding and was a good runner, and at university I thought I’d give pentathlon a go,” she said. “I really just wanted to get back on a horse again, but I also fancied the idea of trying some new sports. I had never shot or fenced before, and my swimming was ropey. I couldn’t even do tumble turns.
“Initially it was just fun. In 1994, when I started, the women’s sport wasn’t even at the Olympics. But I watched the men with interest at Atlanta 1996, and there was a campaign to get the women’s sport included.
“I got selected for the 1997 European Championships, but it clashed with my final medical exams and I couldn’t go. When the UK lottery funding came in, and the Olympics started to look more likely, I was offered a research position by a doctor in Oxford. It meant I could still study but also fit in more training. And then we got the National Training Centre in Bath. From November 1999, I trained full time.”
Having been in the sport for only six years, Steph was still under the radar in terms of becoming a potential medallist. But the unique nature of her sport gave her a chance. “Riding and running were my strengths, but they reckon it takes 10 years to get to international level in fencing,” she said. “I
Primo Nutraceuticals Inc. signs a Memorandum of Understanding for Exclusive Rights to Sell Rapid (Colloidal Gold Method) COVID-19 Test Kits in Canada
COVID-19 Test Kits
COVID-19 Test Kits
VANCOUVER, British Columbia, Oct. 21, 2020 (GLOBE NEWSWIRE) — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF ) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (” PRIMO ” or the “Company”) announces the signing of a Memorandum of Understanding (MOU) with Neo-Nostics ™ (Suzhou) Bioengineering Co. Ltd. Of Su Zhou City, China (“Neo-Nostics”) as the official trade representative for Neo-Nostics ™ with the exclusive rights to apply for licensing and to market and sell the following COVID-19 production Canada: Neo-Nostics ™ 2019-nCoV IgG/IgM Rapid Test Kit (Colloidal Gold Method) (Test Kit).
The Memorandum of Understanding between Primo and Neo-Nostics ™, is effective as of October 13, 2020. Upon successfully receiving product license and approval by Health Canada, Neo-Nostics ™ will grant Primo with “Official Dealer/Distributor Status” in Canada.
The Neo-Nostics ™ 2019-nCoV IgG/IgM Rapid Testing Kit is currently registered with the FDA. Primo will be submitting the application for approval to Health Canada immediately. Neo-Nostics ™ has committed to supporting Primo’s efforts to obtain and maintain all necessary certifications and approvals for the sale and marketing of the Test Kits in Canada by granting access to all necessary documentation and clinical studies concerning the Test Kits.
Follow the link for a video demonstration: http://www.neo-nostics.com/skin/images/mp40.mp4
About the Neo-Nostics ™ Rapid Test Kits
The Neo-Nostics ™ 2019-nCoV Antibody Detection Reagent Kit (Colloidal Gold Method) has the advantage of rapidity, convenience, high accuracy, and can make up for the shortcomings of professional requirements, time consumption and low positive detection rate of PCR nucleic acid detection, and can be used as an important supplementary detection method for the diagnosis of coronal pneumonia.
Through detection and calculation, it is found that the comprehensive accuracy rate of the Neo-Nostics ™ 2019-nCoV IgM Detection Reagent is higher than 95%.
During the worst period of the epidemic in China, the reagent kit was donated to hospitals and the CDC in the most severely infected areas of Hubei for clinical auxiliary diagnosis. At present, the verification reports made by three clinical units prove that the positive detection rate of clinically confirmed cases has reached 92%, which has exceeded the general detection effect. Not only negative or positive results can be detected, but also the early, middle and or recovery period of virus infection can be distinguished by the positive strength of IgM or IgG.
Source: Clinical study report conducted by the Institute of Virology, in the capital city of Hubei, China and The Chinese Academy of Sciences in Beijing, China.
DISCLAIMER: “The Company is not making any express or implied claims that it has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time”.
Clinical Applications of Reagents
This reagent has been used by professionals in China since February 2020 in an area that was the hardest hit and impacted most severely by COVID-19, in the form of clinical auxiliary diagnosis.
The reagent kit was clinically verified by several professionals, hospitals, and universities respectively, and